Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 25 results for "Emixustat Hydrochloride"

ACUCELA : Completes Enrollment in the Emixustat Hydrochloride ...

By a News Reporter-Staff News Editor at Clinical Trials Week -- Acucela Inc. (TOKYO:4589), a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of ... 4 Traders, 1 month ago

1 images for "Emixustat Hydrochloride"

Pharmaceutical Business Review, 1 month ago
Pharmaceutical Business Review

Acucela closes patient enrollment in Phase IIb/III trial of emixustat hydrochloride

Acucela, a US-based clinical-stage biotechnology firm, has completed the patient enrollment in its ongoing Phase IIb/III clinical trial evaluating emixustat in subjects with geographic atrophy (GA) associated with dry age-related macular ...
 Pharmaceutical Business Review1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less